WASHINGTON/SAN FRANCISCO (Reuters) -Apple said on Wednesday it would remove a blood oxygen monitoring feature from two flagship Apple Watch models in the U.S. as the iPhone maker fights a legal battle over patents on the technology behind the feature.
Original article here